Evidence map›Paper›PMID 35140182›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Cotranslational interaction of human EBP50 and ezrin overcomes masked binding site during complex assembly.

Krishnendu Khan, Briana Long, Camelia Baleanu-Gogonea, Valentin Gogonea, Gauravi M Deshpande, Kommireddy Vasu, Paul L Fox

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Cotranslational assembly directs the biogenesis of the mProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Benefits of co-translational complex assembly for cellular fitness.BioEssays : news and reviews in molecular, cellular and developmental biology · 2023
    Article
  4. Review
  5. Multimodal cotranslational interactions direct assembly of the human multi-tRNA synthetase complex.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Krishnendu KhanDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Briana LongDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Camelia Baleanu-GogoneaDepartment of Chemistry, Cleveland State University, Cleveland, OH 44115.
Valentin GogoneaDepartment of Chemistry, Cleveland State University, Cleveland, OH 44115.ORCID 0000-0002-6154-8497
Gauravi M DeshpandeImaging Core, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0002-1621-1553
Kommireddy VasuDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Paul L FoxDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; foxp@ccf.org.ORCID 0000-0002-6033-1528
Cleveland Clinic Lerner College of Medicine · USCleveland State University · US

Funding

Adipokines, Aging, and Alzheimers DiseaseR01AG067146 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 2020 to 2024
$2.4M
The mammalian multi-tRNA synthetase complexR01NS124547 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI PAUL L FOX, Valentin Gogonea · 2022 to 2026
$2.4M
Multisite phosphorylated S6K1 directs a regulatory module determining adipocyte lipid metabolismR01DK123236 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 2020 to 2022
$1.4M
Assay Development for Discovery of a Small Molecule Inhibitor of a Novel Metabolic Pathway that Drives ObesityR01DK124203 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 2020 to 2022
$1.2M
NIA NIH HHS R01 AG067146NIDDK NIH HHS R01 DK123236NIDDK NIH HHS R01 DK124203NINDS NIH HHS R01 NS124547
6 · The paper itself

Abstract

Multiprotein assemblages are the intracellular workhorses of many physiological processes. Assembly of constituents into complexes can be driven by stochastic, domain-dependent, posttranslational events in which mature, folded proteins specifically interact. However, inaccessibility of interacting surfaces in mature proteins (e.g., due to "buried" domains) can obstruct complex formation. Mechanisms by which multiprotein complex constituents overcome topological impediments remain enigmatic. For example, the heterodimeric complex formed by EBP50 and ezrin must address this issue as the EBP50-interacting domain in ezrin is obstructed by a self-interaction that occupies the EBP50 binding site. Here, we show that the EBP50-ezrin complex is formed by a cotranslational mechanism in which the C terminus of mature, fully formed EBP50 binds the emerging, ribosome-bound N-terminal FERM domain of ezrin during

Indexed as

Binding SitesCloning, MolecularCRISPR-Cas SystemsCytoskeletal ProteinsDNA, ComplementaryEzrinGene Expression RegulationGene SilencingHCT116 CellsHEK293 CellsHumansJurkat CellsModels, MolecularPhosphoproteinsProtein BindingProtein BiosynthesisCytoskeletal ProteinsDNA, ComplementaryEzrinPhosphoproteinssodium-hydrogen exchanger regulatory factorSodium-Hydrogen Exchangerscotranslational assemblyEBP50ezrinmRNA translationprotein–protein interaction

Identifiers

PMID35140182
PMCPMC8851480
OpenAlexW4211071235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.